Market Cap 7.05B
Revenue (ttm) 3.22B
Net Income (ttm) 436.04M
EPS (ttm) N/A
PE Ratio 13.22
Forward PE 15.00
Profit Margin 13.53%
Debt to Equity Ratio 0.12
Volume 200
Avg Vol 1,678
Day's Range N/A - N/A
Shares Out 469.91M
Stochastic %K 27%
Beta 0.33
Analysts Buy
Price Target N/A

Company Profile

Ono Pharmaceutical Co., Ltd. produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo intravenous infusion and Kyprolis intravenous injection for malignant tumors; Emend capsule intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; Mektovi, Velexbru, and Braftovi capsules for malignant tumors; and ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv table...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 6 6263 5670
Address:
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, Japan
Latest News on OPHLF
No data available.